Navigation Links
Breakthrough In New Vaccine For Malaria

The trial of a new malaria vaccine on both humans and mice has been successful and could help eradicate the disease that causes at least one million deaths annually, researchers say//.

Pierre Druilhe and his team at the Pasteur Institute here injected an MSP-3-based vaccine into 30 European volunteers who had never had malaria, re-administering it after one month and again after four months, the online edition of Scientific American reported.

Blood samples were taken one month after each injection. These blood samples were then compared to blood samples from people in France who had no immunity to malaria and blood samples from African people with immunity.

Nearly every vaccinated sample produced an immune response to malaria when it was introduced in vitro and 77 percent produced anti-MSP-3 antibodies.

These antibodies proved to be as good at killing the parasite as those from immune adults and, in some cases, better, destroying up to twice as many.

"This type of immune response, characteristic of immune adults living in malaria-endemic regions, requires, under natural conditions, 10 to 15 years of daily exposure to billions of infected red blood cells," Druilhe notes.

Malaria - a parasite carried by certain mosquitoes - sickens more than 300 million people worldwide every year, according to the World Health Organization. Vaccine development has been hindered by the microscopic parasites adaptability and complexity.

The scientists also did in vivo experiments in mice, infecting them with the parasite and then injecting a small amount of the vaccine-produced antibodies.

The antibodies significantly cut the number of parasites in the blood of these animals and in some cases wiped them out entirely - outperforming even the immune systems of naturally resistant humans.

The vaccine also showed long-lasting promise, with blood from some of the immunised individuals show ing strong resistance a year later.

"This is the first malaria vaccine clinical trial to clearly demonstrate anti-parasitic activity by vaccine-induced antibodies," Druilhe said.

--IANS
'"/>




Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Breakthrough in eye treatment
4. Genetic Breakthrough in Common Eye Problem
5. Breakthrough in cancer therapy
6. Breakthrough in Type II Diabetes
7. Breakthrough In Stem Cell Work
8. A Likely Breakthrough For Prostate Cancer Patients
9. New DNA Breakthrough Can Change Future Of Medicine
10. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
11. Breakthrough In Tasmanian Devil Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... critical to ensuring high-quality results and maintaining GMP and USP compliance. In a ... in accordance with GMP requirements " these requirements are explained. The challenge ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists ... to quality care can be limited while the desire to conquer breakouts and eliminate ... acne care for every customer online, today released its inaugural survey on the State ...
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
(Date:3/28/2017)... , March 28, 2017 ... consolidated vendor landscape, with the top three companies, namely ... accounting for a significant 49% of the overall market ... report. The vendor landscape is intensely competitive and has ... the overall market. These factors have restricted the entry ...
Breaking Medicine Technology: